MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME

Cytochrome P450 2E1 was isolated from minipig liver microsomes. The protein has been cloned and the respective cDNA sequenced (GenBank Accession Number AY581116). Minipig CYP2E1 is two residues shorter than its human ortholog. The only difference between pig and minipig sequence is the presence of aspartic acid residue in position 346 contrary to valine in the pig enzyme. Minipig CYP2E1 was shown to be able to convert two prototypical substrates of human CYP2E1, chlorzoxazone and p-nitrophenol, to the respective metabolites. The experiments performed with both the liver microsomal fraction and reconstituted systems with human or minipig CYP2E1 confirmed the similarity of both enzymes. Inhibition with diethyldithiocarbamate gave comparable Ki values for minipig as well as for the human CYP2E1. The results indicate that the systems containing minipig CYP2E1 may be used to model the respective CYP2E1-catalyzed reactions of drug metabolism in humans.

[1]  P. Souček,et al.  Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1. , 2005, Basic & clinical pharmacology & toxicology.

[2]  P. Souček,et al.  Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[3]  E. Hazai,et al.  Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. , 2004, Chemico-biological interactions.

[4]  S. B. Koukouritaki,et al.  Human Hepatic CYP2E1 Expression during Development , 2003, Journal of Pharmacology and Experimental Therapeutics.

[5]  Jin-Young Park,et al.  Construction and assessment of models of CYP2E1: predictions of metabolism from docking, molecular dynamics, and density functional theoretical calculations. , 2003, Journal of medicinal chemistry.

[6]  D. Lewis,et al.  Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  P. Anzenbacher,et al.  Cytochromes P450 and experimental models of drug metabolism , 2002, Journal of cellular and molecular medicine.

[8]  J. Couzin.  Wanted: Pig Transplants That Work , 2002, Science.

[9]  P. Souček,et al.  Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs , 2001, BMC pharmacology.

[10]  D. Farrell,et al.  Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[11]  R. Weaver,et al.  Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[12]  C. Friis,et al.  Cytochrome P450 sex differences in minipigs and conventional pigs. , 1999, Pharmacology & toxicology.

[13]  L. Corcos,et al.  Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. , 1999, Transplantation.

[14]  M. T. Donato,et al.  Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. , 1999, Journal of hepatology.

[15]  R. Witkamp,et al.  Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  F. Guengerich.  Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. , 1997, Chemico-biological interactions.

[17]  F. Berthou,et al.  Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. , 1997, Chemical research in toxicology.

[18]  N. Chauret,et al.  In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[19]  D. Greenblatt,et al.  Biotransformation of Chlorzoxazone by Heptatic Microsomes from Humans and Ten Other Mammalian Species , 1997, Biopharmaceutics & drug disposition.

[20]  C. Lieber,et al.  Cytochrome P-4502E1: its physiological and pathological role. , 1997, Physiological reviews.

[21]  D. Lewis,et al.  Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. , 1997, Toxicology.

[22]  F. Gonzalez,et al.  Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  P. Thomas,et al.  Catalytic and immunochemical characterization of cytochrome P450 isozyme induction in dog liver. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[24]  A. Guillouzo,et al.  Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. , 1993, Chemical research in toxicology.

[25]  F. Guengerich,et al.  Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. , 1993, Archives of biochemistry and biophysics.

[26]  J. Miners,et al.  High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. , 1993, Journal of chromatography.

[27]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[28]  F. Guengerich,et al.  Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.

[29]  Y. Yasukochi,et al.  Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. , 1976, The Journal of biological chemistry.

[30]  A. S. Wiener,et al.  Transplantation , 1963 .

[31]  D. Waxman,et al.  Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. , 2006, Methods in molecular biology.

[32]  D. Waxman,et al.  Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate. , 2006, Methods in molecular biology.

[33]  H. Yamazaki,et al.  Cytochrome P450 reconstitution systems. , 2006, Methods in molecular biology.

[34]  M. Boyd,et al.  Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. , 2000, Archives of biochemistry and biophysics.

[35]  J Kvĕtina,et al.  Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[36]  H. Yamazaki,et al.  Cytochrome P450 reconstitution systems. , 1998, Methods in molecular biology.

[37]  D. Waxman,et al.  Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. , 1998, Methods in molecular biology.

[38]  S. Wrighton,et al.  Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[39]  F. Berthou,et al.  Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1. , 1996, Methods in enzymology.

[40]  K. Snell,et al.  Biochemical toxicology : a practical approach , 1987 .